Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-032835

EVP, R&D & CMO gave up 4,630 shares (to pay taxes)

  • EVP, R&D & CMO acquired 12,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · EVP, R&D & CMO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-23 Exercise or conversion : show line 1 in the form +12,000 12,000 D
2019-05-24 Shares withheld for taxes : show line 2 in the form −4,630 $119.31 $552,405 7,370 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2019-05-23 Exercise or conversion : show line 3 in the form Restricted Stock Units −12,000 12,000 0 D
Loading xslF345X03/doc4.xml…